Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study

Clin Rheumatol. 2009 Nov;28(11):1319-23. doi: 10.1007/s10067-009-1226-8. Epub 2009 Jul 12.

Abstract

Psychiatric manifestations are relatively common in systemic lupus erythematosus (SLE) patients. Since there are factors causing psychiatric manifestations other than SLE, the diagnosis of lupus psychosis (LP) is often difficult. Previous studies disclosed that cerebrospinal fluid (CSF) IL-6 was elevated in SLE patients with neuropsychiatric manifestation. The current studies were therefore designed to examine the efficacy of CSF IL-6 in diagnosis of LP. Multicenter retrospective study was performed with 45 SLE patients who showed psychiatric manifestations between 1993 and 2000. The diagnosis of LP and psychosis due to causes other than SLE (non-LP) was confirmed by retrospective review of the clinical records. Thirty-two of the 45 patients were reconfirmed as LP in the retrospective study. Receiver operating characteristic curve analysis revealed that the sensitivity and specificity of CSF IL-6 for diagnosis of LP were 87.5% and 92.3%, respectively, at the cut-off value of 4.3 pg/ml. These results indicate that CSF IL-6 might be an effective measure in diagnosing LP, although exclusion of infectious meningoencephalitis and cerebrovascular accident is necessary.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Interleukin-6 / cerebrospinal fluid*
  • Lupus Vasculitis, Central Nervous System / cerebrospinal fluid
  • Lupus Vasculitis, Central Nervous System / diagnosis*
  • Lupus Vasculitis, Central Nervous System / psychology
  • Male
  • Mental Disorders / cerebrospinal fluid
  • Mental Disorders / diagnosis*
  • Mental Disorders / psychology
  • Predictive Value of Tests*
  • ROC Curve
  • Reproducibility of Results
  • Retrospective Studies
  • Surveys and Questionnaires

Substances

  • IL6 protein, human
  • Interleukin-6